Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients.

Heymann, Clément J F; Bobin-Dubigeon, Christine; Muñoz-Garcia, Javier; Cochonneau, Denis; Ollivier, Emilie; Heymann, Marie-Françoise; Heymann, Dominique.

Afiliação

Heymann CJF; University of Amsterdam, Academic Medical Center, Swammerdam Institute for Life Sciences, Amsterdam, the Netherlands.
Bobin-Dubigeon C; Institut de Cancérologie de l'Ouest, Tumour Heterogeneity and Precison Medicine Laboratory, Saint-Herblain, France.
Muñoz-Garcia J; Institut de Cancérologie de l'Ouest, Tumour Heterogeneity and Precison Medicine Laboratory, Saint-Herblain, France.
Cochonneau D; Nantes Université, CNRS, UMR6286, US2B, Nantes, France.
Ollivier E; Institut de Cancérologie de l'Ouest, Tumour Heterogeneity and Precison Medicine Laboratory, Saint-Herblain, France.
Heymann MF; Institut de Cancérologie de l'Ouest, Tumour Heterogeneity and Precison Medicine Laboratory, Saint-Herblain, France.
Heymann D; Institut de Cancérologie de l'Ouest, Tumour Heterogeneity and Precison Medicine Laboratory, Saint-Herblain, France.

J Bone Oncol ; 36: 100451, 2022 Oct.

Article em En | MEDLINE | ID: mdl-35990515

Palavras-chave

Gram-negative microbiota; Intratumour bacteria; LBP, LPS-binding protein; LPS, Lipopolysaccharide; MTP-PE, Muramyl tripeptide-phosphatidyl ethanolamine; OS, Osteosarcoma; Osteosarcoma; TLR4, Toll-like receptor 4; Tumour-associated macrophages

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article